What is the prevalence of Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)?
How many people does Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) affect? Does it have the same prevalence in men and women? And in the different countries?
Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) is a rare congenital disorder affecting the female reproductive system. It is characterized by the absence or underdevelopment of the uterus and upper part of the vagina in otherwise normal females. The prevalence of MRKH syndrome is estimated to be approximately 1 in 4,500 to 5,000 female births. Although it is considered a rare condition, it can have significant physical and psychological impacts on affected individuals. Early diagnosis and appropriate medical interventions can help manage the condition and support affected individuals in their reproductive and psychological well-being.
Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) is a rare congenital disorder that affects the development of the female reproductive system. It is characterized by the absence or underdevelopment of the uterus and the upper part of the vagina, while the external genitalia appear normal. MRKH syndrome occurs in approximately 1 in every 4,500 to 5,000 female births.
The exact cause of MRKH syndrome is still unknown, but it is believed to result from a combination of genetic and environmental factors. The condition is typically diagnosed during adolescence when girls fail to start menstruating, and further medical examinations reveal the absence of a uterus.
While MRKH syndrome can be emotionally challenging for affected individuals, it does not affect their overall health or life expectancy. Treatment options include surgical procedures to create a functional vagina and psychological support to help cope with the emotional aspects of the condition.
Efforts are being made to raise awareness about MRKH syndrome and provide support networks for affected individuals to promote understanding and acceptance.
